AZN

Q: What is the price of AstraZeneca (AZN) today?

The current price of AstraZeneca (AZN) is $ 204.64. The stock began the year trading around $ 91.57 and is currently priced at $ 204.64. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does AstraZeneca (AZN) pay dividends?

In the last year, AstraZeneca (AZN) distributed dividends in the month of March, totalizando US$ 2.18. O Dividend Yield referente aos 12 últimos meses é de 1.73%.

Q: Is AstraZeneca (AZN) a good investment?

AstraZeneca (AZN) is currently trading at $ 204.64 with a P/E ratio of 27.54. This represents a 3,511% premium compared to its historical average P/E. Over the past year, the stock paid $ 2.18 in dividends, resulting in a dividend yield of 1.73%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

AstraZeneca PLC

Price

$ 204.64

return (12m)

p/e

27.54

p/bv

6.04

DIVIDEND YIELD

1.73%

AZN price

AstraZeneca

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AZN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals AZN

review the fundamentals of AstraZeneca shares

P/E

27.54

Sector: -4.09 Industry: -4.09

P/Receita (PSR)

4.73

Sector: -3.87 Industry: -3.87

P/BV

6.04

Sector: 1.89 Industry: 1.89

Dividend Yield (DY)

1.73%

Sector: - Industry: -

Payout

47.64%

Sector: - Industry: -

Net Profit Margins

17.19%

Sector: -39.07% Industry: -39.07%

Gross Margin

81.68%

Sector: 37.83% Industry: 37.83%

Margem Operacional

23.69%

Sector: -39.17% Industry: -39.17%

Margem EBIT

28.17%

Sector: - Industry: -

Margem EBITDA

37.11%

Sector: - Industry: -

EV/EBITDA

53.40

Sector: - Industry: -

EV/EBIT

70.34

Sector: - Industry: -

EV/EBITDA

14.14

Sector: -3.91 Industry: -3.91

EV/EBIT

19.51

Sector: -4.18 Industry: -4.18

P/Ativo

2.51

Sector: 1.39 Industry: 1.39

P/Cap Giro

-96.77

Sector: - Industry: -

P/Ativo Circ Líq

-7.73

Sector: - Industry: -

BVPS

30.59

Sector: 1.88 Industry: 1.88

EPS

6.71

Sector: -2.04 Industry: -2.04

Giro de Ativos

0.13

Sector: - Industry: -

ROE

21.93%

Sector: -61.00% Industry: -61.00%

ROIC

13.26%

Sector: -2,142.55% Industry: -2,142.55%

ROA

9.11%

Sector: -61.28% Industry: -61.28%

Dívida Líquida / Patrimônio

0.35

Sector: - Industry: -

Dívida Líquida / EBITDA

2.96

Sector: - Industry: -

Dívida Líquida / EBIT

3.90

Sector: - Industry: -

Dívida Bruta / Patrimônio

0.52

Sector: - Industry: -

Patrimônio / Ativos

0.42

Sector: 0.42 Industry: 0.42

Passivos / Ativos

0.58

Sector: 0.38 Industry: 0.38

Liquidez Corrente

0.91

Sector: - Industry: -

CAGR Receitas 5 Anos

10.07%

Sector: - Industry: -

CAGR Lucros 5 Anos

147.44%

Sector: - Industry: -

FAIR VALUE OF AstraZeneca ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$204.64

Fair Value

$67.96

Upside/Downside Return potential.

-66.79%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals AZN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AZN	27.54	6.04	21.93%	1.73%	$286.16 B	17.19%
JNJ	26.01	6.74	25.92%	2.29%	$547.30 B	21.83%
NBIX	27.51	4.05	14.71%	0.00%	$13.17 B	16.73%
ABEO	4.20	1.88	44.71%	0.00%	$298.65 M	100.00%
PFE	19.27	1.61	8.35%	6.53%	$149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$365.48 B	5.79%
ACAD	9.54	3.04	31.86%	0.00%	$3.73 B	36.49%
ADMA	17.04	5.25	30.78%	0.00%	$2.50 B	28.80%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AZN Historical Dividends

current DY: 1.73%

5-year average DY: 2.26%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/20/2026	03/23/2026	2.17570000
Dividends	08/08/2025	09/08/2025	0.51500000
Dividends	02/21/2025	03/24/2025	1.05000000
Dividends	08/09/2024	09/09/2024	0.50000000
Dividends	02/23/2024	03/25/2024	0.98500000
Dividends	08/11/2023	09/11/2023	0.46500000
Dividends	02/24/2023	03/27/2023	0.98500000
Dividends	08/12/2022	09/12/2022	0.46500000
Dividends	02/25/2022	03/28/2022	0.98500000
Dividends	08/13/2021	09/13/2021	0.45000000
Dividends	02/26/2021	03/29/2021	0.95000000
Dividends	08/14/2020	09/14/2020	0.45000000
Dividends	02/28/2020	03/30/2020	0.95000000
Dividends	08/09/2019	09/09/2019	0.45000000
Dividends	03/01/2019	03/27/2019	0.95000000
Dividends	08/10/2018	09/10/2018	0.45000000
Dividends	02/16/2018	03/19/2018	0.95000000
Dividends	08/11/2017	09/11/2017	0.45000000
Dividends	02/17/2017	03/20/2017	0.95000000
Dividends	08/12/2016	09/12/2016	0.45000000
Dividends	02/19/2016	03/21/2016	0.95000000
Dividends	08/14/2015	09/14/2015	0.45000000
Dividends	02/20/2015	03/23/2015	0.95000000
Dividends	08/15/2014	09/15/2014	0.45000000
Dividends	02/21/2014	03/24/2014	0.95000000
Dividends	08/16/2013	09/16/2013	0.45000000
Dividends	02/15/2013	03/18/2013	0.95000000
Dividends	08/10/2012	09/10/2012	0.45000000
Dividends	02/17/2012	03/19/2012	0.97500000
Dividends	08/08/2011	09/12/2011	0.42500000
Dividends	02/04/2011	03/14/2011	0.92500000
Dividends	08/06/2010	09/13/2010	0.35000000
Dividends	02/05/2010	03/15/2010	0.85500000
Dividends	08/07/2009	09/14/2009	0.29500000
Dividends	02/06/2009	03/16/2009	0.75000000
Dividends	08/08/2008	09/15/2008	0.27500000
Dividends	02/11/2008	03/17/2008	0.67500000
Dividends	08/10/2007	09/17/2007	0.26000000
Dividends	02/09/2007	03/19/2007	0.61500000
Dividends	08/11/2006	09/18/2006	0.24500000
Dividends	02/10/2006	03/20/2006	0.46000000
Dividends	08/12/2005	09/19/2005	0.19000000
Dividends	02/11/2005	03/21/2005	0.32250000
Dividends	08/13/2004	09/20/2004	0.14750000
Dividends	02/20/2004	04/06/2004	0.27000000
Dividends	08/22/2003	10/06/2003	0.12750000
Dividends	02/21/2003	04/07/2003	0.26100000
Dividends	08/23/2002	10/07/2002	0.12800000
Dividends	02/20/2002	04/08/2002	0.26100000
Dividends	08/22/2001	10/05/2001	0.12800000
Dividends	02/23/2001	04/09/2001	0.26100000
Dividends	09/08/2000	10/23/2000	0.12800000
Dividends	03/10/2000	04/17/2000	0.26100000
Dividends	09/10/1999	10/25/1999	0.12800000
Dividends	04/09/1999	04/28/1999	0.17500000

ABOUT AstraZeneca

AstraZeneca PLC

Average Investor10 user rating

4.0 (2 people)

States of America

34 years

Founded: 1992

1993

Time since IPO - 33 years

74.800

Employees

AstraZeneca PLC (States of America) is listed on the Nasdaq and has a market capitalization of $286.16 billion, with shareholders equity totaling $47.38 billion.

The company employs approximately 74.800 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, AstraZeneca PLC reported $60.44 billion in revenue, generating net income of $10.39 billion.

Key financial metrics include a P/E ratio of 27.54, a price-to-book (P/B) ratio of 6.04, and a trailing twelve-month dividend yield of 1.73%.

The company trades under the ticker AZN.

Market cap

$286.16 billion

Net worth

$47.38 billion

$ 47,384,000,000.00

Assets

$114.02 billion

$ 114,015,000,000.00

Total Shares Outstanding

1.55 billion

1,549,000,000

Average Daily Trading Volume

$1.97 million

$ 1,966,872.06

Sector

Healthcare

Industry

Biotecnologia

AZN

AZN revenue and profits

Financial Results AZN

DRAG THE FRAME TO SEE MORE DATA

AZN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 21,75% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$27.11 25,77% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$119.96 60,16% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

ABBV - AbbVie

$210.26 15,72% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

NVO - Novo Nordisk

$39.32 --43,26% (12M)

P/E

12.44

4.25%

ROE

51.50%

P/BV

6.41

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$862.96 21,75% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$27.11 25,77% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$119.96 60,16% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

ABBV - AbbVie

$210.26 15,72% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

NVO - Novo Nordisk

$39.32 --43,26% (12 M)

P/L

12.44

4.25%

ROE

51.50%

P/VP

6.41

Frequently Asked Questions

What is the price of AstraZeneca (AZN) today?

The current price of AstraZeneca (AZN) is $ 204.64. The stock began the year trading around $ 91.57 and is currently priced at $ 204.64. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does AstraZeneca (AZN) pay dividends?

In the last year, AstraZeneca (AZN) distributed dividends in the month of March, totalizando US$ 2.18. O Dividend Yield referente aos 12 últimos meses é de 1.73%.

Is AstraZeneca (AZN) a good investment?

AstraZeneca (AZN) is currently trading at $ 204.64 with a P/E ratio of 27.54. This represents a 3,511% premium compared to its historical average P/E. Over the past year, the stock paid $ 2.18 in dividends, resulting in a dividend yield of 1.73%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy AstraZeneca (AZN) stock?

You can buy AstraZeneca (AZN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol AZN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of AstraZeneca (AZN) yield today?

Over the past month, AstraZeneca (AZN) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 2.69 per share in dividends, resulting in a dividend yield of 1.73%.

If you were to purchase 100 shares of AstraZeneca (AZN) today at the current price of $ 204.64 your total investment would be $ 20,464.00.

Based on historical performance, the investment would have grown to approximately:

$ 20,464.00 after 1 year
$ 20,464.00 after 5 years
$ 20,464.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AZN

AstraZeneca PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AZN

review the fundamentals of AstraZeneca shares

P/E

P/Receita (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Margem Operacional

Margem EBIT

Margem EBITDA

EV/EBITDA

EV/EBIT

EV/EBITDA

EV/EBIT

P/Ativo

P/Cap Giro

P/Ativo Circ Líq

BVPS

EPS

Giro de Ativos

ROE

ROIC

ROA

Dívida Líquida / Patrimônio

Dívida Líquida / EBITDA

Dívida Líquida / EBIT

Dívida Bruta / Patrimônio

Patrimônio / Ativos

Passivos / Ativos

Liquidez Corrente

CAGR Receitas 5 Anos

CAGR Lucros 5 Anos

Graham's Fair Value

current DY: 1.73%

5-year average DY: 2.26%

type

Ex - Dividend Date

payment date

value

AstraZeneca PLC

States of America

34 years

1993

74.800

PROFIT X PRICE AZN

Financial Results AZN

AZN cash flow

Asset, Revenue and Profit Growth - AZN

AZN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions